Cardiovascular Patients With no Standard Modifiable Risk Factors — SMuRF-less-ME1  

Cardiovascular Risk Factors Clinical Trial

Official title: Absence of Standard Modifiable Risk Factors Among 5000 Middle Eastern Patients With Atherosclerotic Cardiovascular Disease: Clinical Profiles and Prevalence of Other Risk Factors and Comorbidities

Status Recruiting

Clinical Trial Summary

A growing number of patients develop atherosclerotic cardiovascular disease (ASCVD) despite the absence of standard modifiable risk factors (SMuRF-less). There is scarcity of studies that address this issue in the Middle Eastern population.

Clinical Trial Description

Atherosclerotic coronary artery disease (ASCAD) claims millions of lives annually on a global level and is the leading cause of death in the Middle East. There are four standard modifiable cardiovascular risk factors (SMuRFs): hypertension, type 2 diabetes mellitus, dyslipidemia, and smoking. These are very common in the Middle East and are crucial to be screened for and addressed in an affective manner. However, an increasing proportion of patients with ASCVD have none of these individual factors (SMuRF-less). Globally, this proportion comprises 11.6% of individuals with stable coronary disease and heart attack. No prior study has addressed the issue of the prevalence of SMuRF-less patients among the whole population of individuals with ASCVD in the Middle East. ;

Related Conditions & MeSH terms

• Atherosclerosis
• Cardiovascular Diseases
• Cardiovascular Risk Factors

• NCT number: NCT06199869
• Study type: Observational
• Source: Jordan Collaborating Cardiology Group
• Contact: Ayman Hammoudeh, MD, FACC
• Phone: +96265001000
• Email: hammoudeh_ayman@yahoo.com
• Status: Recruiting
• Start date: January 22, 2024
• Completion date: January 31, 2025